drugset / Trial / NCT03757130
Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
RandomizedSequentialDouble-blindOther
Summary
The main objective of this study is to assess the safety and tolerability of multiple doses of AMG 598 administered alone or in combination with liraglutide in adults with obesity.
Timeline
- Start
- 2018-11-26
- Primary completion
- 2019-12-16
- Completion
- 2019-12-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AMG 598 | Unknown | 70 mg | Subcutaneous |
| Subject | AMG 598 | Unknown | 210 mg | Subcutaneous |
| Subject | AMG 598 | Unknown | 420 mg | Subcutaneous |
| Background | Liraglutide | Peptide | 3 mg | Subcutaneous |